Industry Drug-Tracking Idea Not Worth The Cost, FDA Says
A top U.S. Food and Drug Administration official on Wednesday objected to an industry proposal to track and trace pharmaceuticals at the lot level, saying the plan would not solve major...To view the full article, register now.
Already a subscriber? Click here to view full article